Warner Pharmaceuticals (688799.SH) announced that it plans to invest no more than RMB 40 million to pledge 17.9767% of the investment of Hainan Heyi Vision Private Equity Investment Fund Partnership (Limited Partnership) (“Heyi Vision”). According to reports, the fund is positioned as an early growth stage venture capital fund in the medical and health sector. It focuses on innovation and value investment in the fields of biotechnology, innovative drugs, medical services, and medical devices, and aims to invest in startups in the medical and health sector in markets such as China and Southeast Asia.
华纳药厂(688799.SH)拟通过基金探索中国、东南亚等市场医疗大健康领域投资机会
Warner Pharmaceuticals (688799.SH) plans to explore investment opportunities in the medical and health sector in markets such as China and Southeast Asia through funds
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.